HR 2474: Strengthening Medicare for Patients and Providers Act. Reps. Raul Ruiz, MD (D-CA); Larry Bucshon, MD (R-IN); Ami Bera, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA). Provides an annual Medicare physician payment update tied to inflation as measured by the Medicare Economic Index (MEI).
HR 4968, the GOLD CARD Act of 2023. Reps Michael Burgess (R-TX); Vincente Gonzalez (D-TX). Exempts physicians who in the previous year received approval for at least 90 percent of their prior authorization requests, from the prior authorization approval process under Medicare Advantage Plans.
HR 6683: Preserving Seniors Access to Physicians Act. Reps. Greg Murphy, MD (R-NC); Brad Wenstrup, DPM (R-OH); Michael Burgess, MD (R-TX); Larry Bucshon, MD (R-IN); Danny Davis (D-IL); Jimmy Panetta (D-CA). Prevents the full 3.4% Medicare physician fee schedule cuts from being implemented on January 1, 2024.
Support implementation of the No Surprises Act (NSA) according to congressional intent. The NSA aimed to fix the problem of unanticipated medical bills and remove patients from the middle of out-of-network billing disputes. However, the Administration crafted rules that disregard congressional intent and insurers are not being held accountable under current policies.
HR 977/S470: Patient Access to Higher Quality Health Act of 2023. Rep. Michael Burgess (R-TX) Sen. James Lankford (R-OK). This bill repeals provisions under the Stark Law (i.e., the Physician Self-Referral Law) that limit, for purposes of Medicare participation, self-referrals by newly constructed or expanded physician-owned hospitals.
HR 2630/S 652: Safe Step Act. Reps. Brad Wenstrup, DPM (R-OH); Raul Ruiz, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA) Sens. Lisa Murkowski (R-AK); Maggie Hassan (D-NH); Roger Marshall, MD (R-KS). Requires group health plans to establish a clear and transparent process to request an exception to step therapy protocols in specified cases.
Support reforming prior authorization. Advocate for prior authorization policies that are more seamless, automated, and transparent for physicians and their patients.
HR: 6545: Physician Fee Schedule Update and Improvements Act. Reps. Mariannette Miller-Meeks (R-IA): Larry Bucshon, MD (R-IN); Kim Schrier, MD (D-WA); Robin Kelly (D-IL); Michael Burgess, MD (R-TX); Greg Murphy, MD (R-NC); Brad Wenstrup, DPM (R-OH); Ami Bera, MD (D-CA); Tony Cardenas (D-CA); Raul Ruiz, MD (D-CA). Increases the budget neutrality from $20 million to $53 million would allow for greater flexibility in determining pricing adjustments for services without leading to harmful payment cuts for doctors.
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries to address the most significant gaps for military personnel with orthopaedic injuries.
HR 2584 / S 2768: Safety from Violence for Healthcare Employees Act (SAVE Act). Reps. Larry Bucshon, MD (R-IN); Madeleine Dean (D-PA); Sens. Joe Manchin (D-WV); Marco Rubio (R-FL). Enhanced penalties for assaulting or intimidating a hospital employee or those contracted by a hospital.
HR 2819: Good Samaritan Health Professionals Act of 2023. Reps. Larry Bucshon, MD (R-IN); Raul Ruiz, MD (D-CA). Limits the liability of health care professionals who volunteer to provide health care services in response to specified public health or national emergencies or major disasters.
HR 1202/S.704: Resident Education Deferred Interest (REDI) Act. Reps. Brian Babin, DDS (R-TX); Chrissy Houlahan (D-PA); Sens. Jacky Rosen (D-NV); John Boozman (R-AR). Allows borrowers to defer their student loans interest-free while they are serving a medical or dental internship or residency program.
Duration: February 14, 2008
to
present
General Issues: Medicare/Medicaid , Insurance , Medical/Disease Research/Clinical Labs , Labor Issues/Antitrust/Workplace , Health Issues , Science/Technology , Budget/Appropriations , Consumer Issues/Safety/Protection , Defense , Homeland Security , Torts
Spending: about $27,452,566 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Food & Drug Administration (FDA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 19.
Original Filing: 301565382.xml
Lobbying Issues
HR 2474: Strengthening Medicare for Patients and Providers Act. Reps. Raul Ruiz, MD (D-CA); Larry Bucshon, MD (R-IN); Ami Bera, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA). Provides an annual Medicare physician payment update tied to inflation as measured by the Medicare Economic Index (MEI).
HR 4968, the GOLD CARD Act of 2023. Reps Michael Burgess (R-TX); Vincente Gonzalez (D-TX). Exempts physicians who in the previous year received approval for at least 90 percent of their prior authorization requests, from the prior authorization approval process under Medicare Advantage Plans.
HR 6683: Preserving Seniors Access to Physicians Act. Reps. Greg Murphy, MD (R-NC); Brad Wenstrup, DPM (R-OH); Michael Burgess, MD (R-TX); Larry Bucshon, MD (R-IN); Danny Davis (D-IL); Jimmy Panetta (D-CA). Prevents the full 3.4% Medicare physician fee schedule cuts from being implemented on January 1, 2024.
Support implementation of the No Surprises Act (NSA) according to congressional intent. The NSA aimed to fix the problem of unanticipated medical bills and remove patients from the middle of out-of-network billing disputes. However, the Administration crafted rules that disregard congressional intent and insurers are not being held accountable under current policies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 977/S470: Patient Access to Higher Quality Health Act of 2023. Rep. Michael Burgess (R-TX) Sen. James Lankford (R-OK). This bill repeals provisions under the Stark Law (i.e., the Physician Self-Referral Law) that limit, for purposes of Medicare participation, self-referrals by newly constructed or expanded physician-owned hospitals.
HR 2630/S 652: Safe Step Act. Reps. Brad Wenstrup, DPM (R-OH); Raul Ruiz, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA) Sens. Lisa Murkowski (R-AK); Maggie Hassan (D-NH); Roger Marshall, MD (R-KS). Requires group health plans to establish a clear and transparent process to request an exception to step therapy protocols in specified cases.
Support reforming prior authorization. Advocate for prior authorization policies that are more seamless, automated, and transparent for physicians and their patients.
HR: 6545: Physician Fee Schedule Update and Improvements Act. Reps. Mariannette Miller-Meeks (R-IA): Larry Bucshon, MD (R-IN); Kim Schrier, MD (D-WA); Robin Kelly (D-IL); Michael Burgess, MD (R-TX); Greg Murphy, MD (R-NC); Brad Wenstrup, DPM (R-OH); Ami Bera, MD (D-CA); Tony Cardenas (D-CA); Raul Ruiz, MD (D-CA). Increases the budget neutrality from $20 million to $53 million would allow for greater flexibility in determining pricing adjustments for services without leading to harmful payment cuts for doctors.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries to address the most significant gaps for military personnel with orthopaedic injuries.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2584 / S 2768: Safety from Violence for Healthcare Employees Act (SAVE Act). Reps. Larry Bucshon, MD (R-IN); Madeleine Dean (D-PA); Sens. Joe Manchin (D-WV); Marco Rubio (R-FL). Enhanced penalties for assaulting or intimidating a hospital employee or those contracted by a hospital.
HR 2819: Good Samaritan Health Professionals Act of 2023. Reps. Larry Bucshon, MD (R-IN); Raul Ruiz, MD (D-CA). Limits the liability of health care professionals who volunteer to provide health care services in response to specified public health or national emergencies or major disasters.
HR 1202/S.704: Resident Education Deferred Interest (REDI) Act. Reps. Brian Babin, DDS (R-TX); Chrissy Houlahan (D-PA); Sens. Jacky Rosen (D-NV); John Boozman (R-AR). Allows borrowers to defer their student loans interest-free while they are serving a medical or dental internship or residency program.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2023
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 19.
Original Filing: 301530792.xml
Lobbying Issues
HR 2474: Strengthening Medicare for Patients and Providers Act. Reps. Raul Ruiz, MD (D-CA); Larry Bucshon, MD (R-IN); Ami Bera, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA) Provides an annual Medicare physician payment update tied to inflation as measured by the Medicare Economic Index (MEI).
HR 4968, the GOLD CARD Act of 2023. Reps Michael Burgess (R-TX); Vincente Gonzalez (D-TX) Exempts physicians who in the previous year received approval for at least 90 percent of their prior authorization requests, from the prior authorization approval process under Medicare Advantage Plans.
HR 6683: Preserving Seniors Access to Physicians Act. Reps. Greg Murphy, MD (R-NC); Brad Wenstrup, DPM (R-OH); Michael Burgess, MD (RTX); Larry Bucshon, MD (R-IN); Danny Davis (D-IL); Jimmy Panetta (D-CA) Prevents the full 3.4% Medicare physician fee schedule cuts from being implemented on January 1, 2024.
Support implementation of the No Surprises Act (NSA) according to congressional intent. The NSA aimed to fix the problem of unanticipated medical bills and remove patients from the middle of out-of-network billing disputes. However, the Administration crafted rules that disregard congressional intent and insurers are not being held accountable under current policies.
Support permanently delaying implementation of G2211 add-on code. This code was designed to give primary care additional compensation for complex visits but is duplicative of updates already made to the physician fee schedule. G2211 accounts for 90% of the cut physicians are facing in 2024 due to budget neutrality.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 977/S470: Patient Access to Higher Quality Health Act of 2023. Rep. Michael Burgess (R-TX) Sen. James Lankford (R-OK) This bill repeals provisions under the Stark Law (i.e., the Physician Self-Referral Law) that limit, for purposes of Medicare participation, self-referrals by newly constructed or expanded physician-owned hospitals.
HR 2630/S 652: Safe Step Act. Reps. Brad Wenstrup, DPM (R-OH); Raul Ruiz, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA) Sens. Lisa Murkowski (R-AK); Maggie Hassan (D-NH); Roger Marshall (R-KS) Requires group health plans to establish a clear and transparent process to request an exception to step therapy protocols in specified cases.
Support reforming prior authorization. Advocate for prior authorization policies that are more seamless, automated, and transparent for physicians and their patients.
Support extending and expanding telehealth.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries to address the most significant gaps for military personnel with orthopaedic injuries.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2584 / S 2768: Safety from Violence for Healthcare Employees Act (SAVE Act). Reps. Larry Bucshon, MD (R-IN); Madeleine Dean (D-PA); Sens. Joe Manchin (D-WV); Marco Rubio (R-FL) Enhanced penalties for assaulting or intimidating a hospital employee or those contracted by a hospital.
HR 2819: Good Samaritan Health Professionals Act of 2023. Reps. Larry Bucshon, MD (R-IN); Raul Ruiz, MD (D-CA) Limits the liability of health care professionals who volunteer to provide health care services in response to specified public health or national emergencies or major disasters.
HR 1202/S.704: Resident Education Deferred Interest (REDI) Act. Reps. Brian Babin, DDS (R-TX); Chrissy Houlahan (D-PA); Sens. Jacky Rosen (D-NV); John Boozman (R-AR) Allows borrowers to defer their student loans interest-free while they are serving a medical or dental internship or residency program.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2023
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 18, 2023.
Original Filing: 301504566.xml
Lobbying Issues
HR 2474: Strengthening Medicare for Patients and Providers Act
Reps. Raul Ruiz, MD (D-CA); Larry Bucshon, MD (R-IN); Ami Bera, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA) Provides an annual Medicare physician payment update tied to inflation as measured by the Medicare Economic Index (MEI).
HR 4968, the GOLD CARD Act of 2023
Reps Michael Burgess (R-TX); Vincente Gonzalez (D-TX)
Exempt qualifying providers from prior authorization requirements under Medicare Advantage Plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 977/S470: Patient Access to Higher Quality Health Act of 2023
Rep. Michael Burgess (R-TX)
Sen. James Lankford (R-OK)
This bill repeals provisions under the Stark Law (i.e., the Physician Self-Referral Law) that limit, for purposes of Medicare participation, self-referrals by newly constructed or expanded physician-owned hospitals.
HR 2630/S 652: Safe Step Act
Reps. Brad Wenstrup, DPM (R-OH); Raul Ruiz, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA)
Sens. Lisa Murkowski (R-AK); Maggie Hassan (D-NH); Roger Marshall (R-KS)
Requires group health plans to establish a clear and transparent process to request an exception to step therapy protocols in specified cases.
Support reforming prior authorization procedures to be more seamless, automated and transparent for physicians
Support extending and expanding telehealth
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2584: Safety from Violence for Healthcare Employees Act (SAVE Act)
Reps. Larry Bucshon, MD (R-IN); Madeleine Dean (D-PA)
Enhanced penalties for assaulting an individual employed by a hospital or an entity contracting with a hospital or other medical facility.
HR 2819: Good Samaritan Health Professionals Act of 2023
Reps. Larry Bucshon, MD (R-IN); Raul Ruiz, MD (D-CA)
Limits the liability of health care professionals who volunteer to provide health care services in response to specified public health or national emergencies or major disasters.
HR 1202/S.704: Resident Education Deferred Interest (REDI) Act
Reps. Brian Babin (R-TX); Chrissy Houlahan (D-PA)
Allows borrowers to defer their student loans interest-free while they are serving a medical or dental internship or residency program.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2023
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 19, 2023.
Original Filing: 301484138.xml
Lobbying Issues
HR 2474: Strengthening Medicare for Patients and Providers Act
Reps. Raul Ruiz, MD (D-CA); Larry Bucshon, MD (R-IN); Ami Bera, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA) Provides an annual Medicare physician payment update tied to inflation as measured by the Medicare Economic Index (MEI).
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 977/S470: Patient Access to Higher Quality Health Act of 2023
Rep. Michael Burgess (R-TX)
Sen. James Lankford (R-OK)
This bill repeals provisions under the Stark Law (i.e., the Physician Self-Referral Law) that limit, for purposes of Medicare participation, self-referrals by newly constructed or expanded physician-owned hospitals.
HR 2630/S 652: Safe Step Act
Reps. Brad Wenstrup, DPM (R-OH); Raul Ruiz, MD (D-CA); Mariannette Miller-Meeks, MD (R-IA)
Sens. Lisa Murkowski (R-AK); Maggie Hassan (D-NH); Roger Marshall (R-KS)
Requires group health plans to establish a clear and transparent process to request an exception to step therapy protocols in specified cases.
Support reforming prior authorization procedures to be more seamless, automated and transparent for physicians
Support extending and expanding telehealth
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2584: Safety from Violence for Healthcare Employees Act (SAVE Act)
Reps. Larry Bucshon, MD (R-IN); Madeleine Dean (D-PA)
Enhanced penalties for assaulting an individual employed by a hospital or an entity contracting with a hospital or other medical facility.
HR 2819: Good Samaritan Health Professionals Act of 2023
Reps. Larry Bucshon, MD (R-IN); Raul Ruiz, MD (D-CA)
Limits the liability of health care professionals who volunteer to provide health care services in response to specified public health or national emergencies or major disasters.
HR 1202/S.704: Resident Education Deferred Interest (REDI) Act
Reps. Brian Babin (R-TX); Chrissy Houlahan (D-PA)
Allows borrowers to defer their student loans interest-free while they are serving a medical or dental internship or residency program.
WE OPPOSE HR 618: Improving Access to Workers Compensation for Injured Federal Workers Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2023
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 17, 2023.
Original Filing: 301453669.xml
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated and transparent for physicians: Improving Seniors Timely Access to Care Act.
Support the Gold Card Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support extending and expanding telehealth
Oppose Improving Access to Workers Compensation for Injured Federal Workers Act. Would inappropriately permit nurse practitioners and physician assistants to diagnose, prescribe, treat and certify an injury for federal workers compensation claims
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Support legislation to lift the ban on expanding or building new physician owned hospitals
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2022
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42022 on June 27, 2023
Original Filing: 301472502.xml
Lobbying Issues
Support H.R. 8800, Supporting Medicare Providers Act of 2022. This legislation provides a 4.42% update to the conversion factor.
Support HR 7995, Gold Card Act'
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated and transparent for physicians: HR 3173/ S.3018, Improving Seniors Timely Access to Care Act of 2021.
Support extending and expanding telehealth: HR 1332 and S 368, The Telehealth Modernization Act; HR 2903 and S 1512, The Connect for Health Act; HR 4480 The Telehealth Coverage and Payment Parity Act and HR 2168 The Expanded Telehealth Access Act.
Oppose H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act. Would inappropriately permit nurse practitioners and physician assistants to diagnose, prescribe, treat and certify an injury for federal workers compensation claims.
Ensure relevant traveling physicians can appropriately treat their patients by supporting HR7259 the Medical Controlled Substances Transportation Act of 2022.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Support legislation aimed at accelerating medical research and patient access to novel therapeutics H.R. 6000 the Cures 2.0 Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Support legislation to protect healthcare workers from threats, harassment and violence. H.R. 7961 the Safety From Violence for Healthcare Employees (SAVE) Act
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2022
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301439616.xml
Lobbying Issues
Support H.R. 8800, Supporting Medicare Providers Act of 2022. This legislation provides a 4.42% update to the conversion factor.
Support HR 7995, Gold Card Act'
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated and transparent for physicians: HR 3173/ S.3018, Improving Seniors Timely Access to Care Act of 2021.
Support extending and expanding telehealth: HR 1332 and S 368, The Telehealth Modernization Act; HR 2903 and S 1512, The Connect for Health Act; HR 4480 The Telehealth Coverage and Payment Parity Act and HR 2168 The Expanded Telehealth Access Act.
Oppose H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act. Would inappropriately permit nurse practitioners and physician assistants to diagnose, prescribe, treat and certify an injury for federal workers compensation claims.
Ensure relevant traveling physicians can appropriately treat their patients by supporting HR7259 the Medical Controlled Substances Transportation Act of 2022.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Support legislation aimed at accelerating medical research and patient access to novel therapeutics H.R. 6000 the Cures 2.0 Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Support legislation to protect healthcare workers from threats, harassment and violence. H.R. 7961 the Safety From Violence for Healthcare Employees (SAVE) Act
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2022
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 19, 2022.
Original Filing: 301410914.xml
Lobbying Issues
Support H.R. 8800, Supporting Medicare Providers Act of 2022. This legislation provides a 4.42% update to the conversion factor.
Support HR 7995, Gold Card Act of 2022 Exempting physicians from prior authorization requirements under Medicare Advantage plans if at least 90% of the physicians requests were approved during the previous plan year.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated and transparent for physicians: HR 3173/ S.3018, Improving Seniors Timely Access to Care Act of 2021.
Support extending and expanding telehealth: HR 1332 and S 368, The Telehealth Modernization Act; HR 2903 and S 1512, The Connect for Health Act; HR 4480 The Telehealth Coverage and Payment Parity Act and HR 2168 The Expanded Telehealth Access Act.
Oppose H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act. Would inappropriately permit nurse practitioners and physician assistants to diagnose, prescribe, treat and certify an injury for federal workers compensation claims.
Ensure relevant traveling physicians can appropriately treat their patients by supporting H.R. 7259 the Medical Controlled Substances Transportation Act of 2022
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Support legislation aimed at accelerating medical research and patient access to novel therapeutics H.R. 6000 the Cures 2.0 Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Support legislation to protect healthcare workers from threats, harassment and violence. H.R. 7961 the Safety From Violence for Healthcare Employees (SAVE) Act
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2022
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 18, 2022.
Original Filing: 301382862.xml
Lobbying Issues
Support legislative efforts to counter medicare cuts and sequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated and transparent for physicians. HR 1373/S.3018 "Improving Seniors' Timely Access to Care Act of 2021"
Support extending and expanding telehealth. HR 1332 and S 368, "The Telehealth Modernization Act" HR 2903 and S 1512, "The Connect for Health Act" HR4480 "The Telehealth Coverage and Payment Parity Act" and HR 2168 "The Expanded Telehealth Access Act"
Educate lawmakers on scope of practice issues by engaging on HR 6087 the "Improving Access to Workers' Compensation for Injured Federal Workers Act of 2022"
Ensure relevant traveling physicians can appropriately treat their patients by supporting HR 7259 the "Medical Controlled Substances Transportation Act of 2022"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Support legislation aimed at accelerating medical research and patient access to novel therapeutics HR 6000 the "Cures 2.0 Act"
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Support legislation to protect healthcare workers from threats, harassment and violence. HR 7961 the "Safety from Violence for Healthcare Employees (SAVE) Act"
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2022
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 18, 2022.
Original Filing: 301358515.xml
Lobbying Issues
Support legislative efforts to counter medicare cuts and dequestration.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated and transparent
for physicians. HR 1373, "Improving Seniors' Timely Access to Care Act of 2021"
Support extending and expanding telehealth. HR 1332 and S 368, "The Telehealth Modernization Act" HR 2903 and S 1512, "The Connect for Health Act" HR4480 "The Telehealth Coverage and Payment Parity Act" and HR 2168 "The Expanded Telehealth Access Act"
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a
competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301337507.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated, and transparent
for physicians. HR 1373, "Improving Seniors' Timely Access to Care Act of 2021"
Support extending and expanding telehealth. HR 1332 and S 368, "The Telehealth Modernization Act" HR 2903 and S 1512, "The Connect for Health Act" HR4480 "The Telehealth Coverage and Payment Parity Act" and HR 2168 "The Expanded Telehealth Access Act"
Support appropriate use criteria in Labor HHS appropriations.
Support efforts to effectively implement the No Surprises Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reducing and preventing mental and behavioral health conditions for health care professionals. HR 1667 and S 610, The Dr. Lorna Breen Health Care Provider Protection Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Supporting the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a
competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301303860.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated, and transparent
for physicians. HR 1373, "Improving Seniors' Timely Access to Care Act of 2021"
Support extending and expanding telehealth. HR 1332 and S 368, "The Telehealth Modernization Act" HR 2903 and S 1512, "The Connect for Health Act"
Support appropriate use criteria in Labor HHS appropriations.
Support extending and expanding telehealth. HR 1332 and S 368, The Telehealth Modernization Act. HR 2903 and S 1512, The Connect for Health Act. HR 4480 The Telehealth Coverage and Payment Parity Act. HR 2168 The Expanded Telehealth Access Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reducing and preventing mental and behavioral health conditions for health care professionals. HR 1667 and S 610, The Dr. Lorna Breen Health Care Provider Protection Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Supporting the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a
competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q32021 on Oct. 19, 2021
Original Filing: 301304261.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reforming prior authorization procedures to be more seamless, automated, and transparent
for physicians. HR 1373, "Improving Seniors' Timely Access to Care Act of 2021"
Support extending and expanding telehealth. HR 1332 and S 368, "The Telehealth Modernization Act" HR 2903 and S 1512, "The Connect for Health Act"
Support appropriate use criteria in Labor HHS appropriations.
Support extending and expanding telehealth. HR 1332 and S 368, The Telehealth Modernization Act. HR 2903 and S 1512, The Connect for Health Act. HR 4480 The Telehealth Coverage and Payment Parity Act. HR 2168 The Expanded Telehealth Access Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support reducing and preventing mental and behavioral health conditions for health care professionals. HR 1667 and S 610, The Dr. Lorna Breen Health Care Provider Protection Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Supporting the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a
competitive grant program that funds research pertaining to extremity war injuries.
Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 19, 2021.
Original Filing: 301282538.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reforming prior authorization procedures to be more seamless, automated, and transparent
for physicians. HR 1373, "Improving Seniors' Timely Access to Care Act of 2021"
Support extending and expanding telehealth. HR 1332 and S 368, "The Telehealth Modernization Act" HR 2903 and S 1512, "The Connect for Health Act"
Support appropriate use criteria in Labor HHS appropriations.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1667 and S. 610 "Dr. Lorna Breen Health Care Provider Protection Act" Helps reduce
and prevent mental and behavioral health conditions for health care professionals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Supporting the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a
competitive grant program that funds research pertaining to extremity war injuries.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2021
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 15, 2021.
Original Filing: 301253400.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reforming prior authorization procedures to be more seamless, automated, and transparent
for physicians.
Working to extend telehealth payment parity and ending geographic origination site
restriction.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1667 and S. 610 "Dr. Lorna Breen Health Care Provider Protection Act" Helps reduce
and prevent mental and behavioral health conditions for health care professionals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Supporting the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a
competitive grant program that funds research pertaining to extremity war injuries.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2020
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301236556.xml
Lobbying Issues
HR 3107, Improving Seniors' Timely Access to Care Act
HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3630, The No Surprises Act
S 4317, Safe to Work Act
HR 7168/S 3547, Creating Capacity for Communities in Need Act
S.350, the Competitive Health Insurance Reform Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 7059, Coronavirus Provider Protection Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 20, 2020.
Original Filing: 301222769.xml
Lobbying Issues
HR 2282 and S. 966, The Medicare Care Coordination Improvement Act
HR 3107, Improving Seniors' Timely Access to Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3502, Protecting Patients from Surprise Medical Bills Act-Fair Negotiation for Out-of-Network medical Services
HR 3062, Patient Access to Higher Quality Health Care Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1418 and S.350, the Competitive Health Insurance Reform Act of 2019
Incorporate the RUC-recommended work and time incremental increases for the revised office/outpatient visit E/M codes in all the global codes
Urge CMS to reassess the pace at which procedures are removed to the Inpatient Only List (IPO)
Telehealth policies that promote equal reimbursement with in-person visits
Agencies Lobbied
U.S. Senate
Lobbying Issues
S 1350, The Good Samaritan Health Professionals Act
CARES Act, Support funding relief (Paycheck Protection Program and Loan Forgiveness) for Surgeon's practices in the Coronavirus Aid, Relief, and Economic Security Act
Medical Liability Reform - H.R. 7059, Coronavirus Provider Protection Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 20, 2020.
Original Filing: 301199547.xml
Lobbying Issues
HR 2282 and S. 966, The Medicare Care Coordination Improvement Act
HR 3107, Improving Seniors' Timely Access to Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3502, Protecting Patients from Surprise Medical Bills Act-Fair Negotiation for Out-of-Network medical Services
HR 3062, Patient Access to Higher Quality Health Care Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1418 and S.350, the Competitive Health Insurance Reform Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
S 1350, The Good Samaritan Health Professionals Act
CARES Act, Support funding relief (Paycheck Protection Program and Loan Forgiveness) for Surgeon's practices in the Coronavirus Aid, Relief, and Economic Security Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 20, 2020.
Original Filing: 301177239.xml
Lobbying Issues
HR 2282 and S. 966, The Medicare Care Coordination Improvement Act
HR 3107, Improving Seniors' Timely Access to Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Peer Reviewed Orthopaedic Research program
HR 506, The Hospital Competition Act
HR 3502, Protecting Patients from Surprise Medical Bills Act-Fair Negotiation for Out-of-Network medical Services
HR 3062, Patient Access to Higher Quality Health Care Act of 2019
HR 1554, The Resident Education Deferred Interest Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1418 and S.350, the Competitive Health Insurance Reform Act of 2019
HR 6365 and S 3559, Support for the Immediate Relief for Rural Facilities and Providers Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
S 1350, The Good Samaritan Health Professionals Act
CARES Act, Support funding relief (Paycheck Protection Program and Loan Forgiveness) for Surgeon's practices in the Coronavirus Aid, Relief, and Economic Security Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2020.
Original Filing: 301122241.xml
Lobbying Issues
HR 2282 and S. 966, The Medicare Care Coordination Improvement Act
HR 3107, Improving Seniors' Timely Access to Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Peer Reviewed Orthopaedic Research program
HR 506, The Hospital Competition Act
HR 3502, Protecting Patients from Surprise Medical Bills Act-Fair Negotiation for Out-of-Network medical Services
HR 3062, Patient Access to Higher Quality Health Care Act of 2019
HR 1554, The Resident Education Deferred Interest Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1418 and S.350, the Competitive Health Insurance Reform Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
S 1350, The Good Samaritan Health Professionals Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 20, 2019.
Original Filing: 301072380.xml
Lobbying Issues
HR 2282 and S. 966, The Medicare Care Coordination Improvement Act
HR 3107, Improving Seniors' Timely Access to Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Peer Reviewed Orthopaedic Research program
HR 506, The Hospital Competition Act
HR 3502, Protecting Patients from Surprise Medical Bills Act-Fair Negotiation for Out-of-Network medical Services
HR 3062, Patient Access to Higher Quality Health Care Act of 2019
HR 1554, The Resident Education Deferred Interest Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1418 and S.350, the Competitive Health Insurance Reform Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 4099, The ACCESS Act - Medical Liability Reform
S 1350, The Good Samaritan Health Professionals Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 19, 2019.
Original Filing: 301051200.xml
Lobbying Issues
HR 2282 and S. 966, The Medicare Care Coordination Improvement Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Peer Reviewed Orthopaedic Research program
HR 506, The Hospital Competition Act
HR 3502, Protecting Patients from Surprise Medical Bills Act-Fair Negotiation for Out-of-Network medical Services
HR 3062, Patient Access to Higher Quality Health Care Act of 2019
HR 1554, The Resident Education Deferred Interest Act
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1418 and S.350, the Competitive Health Insurance Reform Act of 2019
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 19, 2019.
Original Filing: 301031906.xml
Lobbying Issues
HR 2282, The Medicare Care Coordination Improvement Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Peer Reviewed Orthopaedic Research program
HR 506, The Hospital Competition Act
Protecting Patients from Surprise Medical Bills Act (not introduced yet)
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1418, the Competitive Health Insurance Reform Act of 2019
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 22, 2019.
Original Filing: 301016921.xml
Lobbying Issues
HR7084 Hospital Competition Act of 2018
HR1156/S1133 Patient Access to Higher Quality Health Care Act of 2017
HR4206/S2051 Medicare Care Coordination Improvement Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR6378/HR7328/S2851 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR302-Sports Medicine Licensure Clarity Act of 2017- S.808
HR5734 Resident Education Deferred Interest Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 17, 2018.
Original Filing: 300986651.xml
Lobbying Issues
HR6 The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Community Act
HR302/S.808 The Sports Medicine Licensure Clarity Act
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR 1215 Protecting Access to Care Act (Medical Liability Reform)
Appropriations: Peer-Reviewed Orthopaedic Research Program (PRORP) and NIH funding
HR1492 Medical Controlled Substances Transportation Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviewed Orthopaedic Research Program
Opioid legislation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR302-Sports Medicine Licensure Clarity Act of 2017- S.808
HR 1215 Protecting Access to Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 19, 2018.
Original Filing: 300970379.xml
Lobbying Issues
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR4206 & S2051 The Medicare Care Coordination Improvement Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviewed Orthopaedic Research Program
HR880 & S1022 Mission Zero Act
Opioid legislation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR1704-Access Act of 2017
HR302-Sports Medicine Licensure Clarity Act of 2017- S.808
HR 1215 Protecting Access to Care Act
HR1876-Good Samaritan Health Professionals Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 19, 2018.
Original Filing: 300951649.xml
Lobbying Issues
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR4206 & S2051 The Medicare Care Coordination Improvement Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviewed Orthopaedic Research Program
HR880 & S1022 Mission Zero Act
Opioid legislation
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR1704-Access Act of 2017
HR302-Sports Medicine Licensure Clarity Act of 2017- S.808
HR 1215 Protecting Access to Care Act
HR1876-Good Samaritan Health Professionals Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42017 on Feb. 6, 2018
Original Filing: 300939842.xml
Lobbying Issues
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR849 Protecting Seniors Access to Medicare Act of 2017
HR 1215 Protecting Access to Care Act
HR 1492 Medical Controlled Substance Transportation Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviews Orthopaedic Research Program
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR1704-Access Act of 2017
HR302-Sports Medicine Licensure Clarity Act of 2017- S.808
HR 1215 Protecting Access to Care Act
HR1876-Good Samaritan Health Professionals Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 19, 2018.
Original Filing: 300930340.xml
Lobbying Issues
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR849 Protecting Seniors Access to Medicare Act of 2017
HR 1215 Protecting Access to Care Act
HR 1492 Medical Controlled Substance Transportation Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviews Orthopaedic Research Program
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR1704-Access Act of 2017
HR302-Sports Medicine Licensure Clarity Act of 2017- S.808
HR 1215 Protecting Access to Care Act
HR1876-Good Samaritan Health Professionals Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 18, 2017.
Original Filing: 300907769.xml
Lobbying Issues
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR849 Protecting Seniors Access to Medicare Act of 2017
HR 1215 Protecting Access to Care Act
HR 1492 Medical Controlled Substance Transportation Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviews Orthopaedic Research Program
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR1704-Access Act of 2017
HR302-Sports Medicine Licensure Clarity Act of 2017- S.808
HR 1215 Protecting Access to Care Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 18, 2017.
Original Filing: 300887097.xml
Lobbying Issues
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR849 Protecting Seniors Access to Medicare Act of 2017
HR 1215 Protecting Access to Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviews Orthopaedic Research Program
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR1704-Access Act of 2017
HR302-Sports Medicine Licensure Clarity Act of 2017
HR 1215 Protecting Access to Care Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 20, 2017.
Original Filing: 300876738.xml
Lobbying Issues
HR1156 Patient Access to Higher Quality Health Care Act of 2017
HR849 Protecting Seniors Access to Medicare Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding for the Peer Reviews Orthopaedic Research Program
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR1704-Access Act of 2017
HR302-Sports Medicine Licensure Clarity Act of 2017
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42016 on Aug. 22, 2017
Original Filing: 300899953.xml
Lobbying Issues
Support H.R. 105: Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the federal antitrust laws in their negotiations with health plans and health insurance carriers
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services.
Support HR 3940, Meaningful Use Hardship Relief Act of 2015, which provided physicians with a hardship exemption to Stage 2 meaningful use regulations
Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Track ICD 10 implementation
Support HR 4848 The Healthy Inpatient Procedures Act
Support HR 3014: Medical Controlled Substances Transportation Act of 2015: This bill amends the Controlled Substances Act to allow a physician to transport controlled substances to another practice setting or disaster area if the physician is registered to dispense, or conduct research with, controlled substances listed on schedules II, III, IV, or V, and the physician enters into a specific agreement with the Drug Enforcement Administration (DEA).
Repeal the Independent Payment Advisory Board (IPAB);
Track Implementation of the Affordable Care Act;
Support S. 2822 and HR 5001, The Flexibility in Electronic Health Record Reporting Act;
Support HR 2513, The Promoting Access, Competition and Equity (PACE) Act;
Support HR 4848 The Healthy Inpatient Procedures Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding of the Peer Reviewed Orthopaedic Research Program
Support the 21st Century Cures Bill
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medical Liability Reform: Work to reduce the excessive burden the liability system places on the health care delivery system
Support HR 921/S. 689 - To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42016 on Aug. 22, 2017
Original Filing: 300899954.xml
Lobbying Issues
Support H.R. 105: Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the federal antitrust laws in their negotiations with health plans and health insurance carriers
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services.
Support HR 3940, Meaningful Use Hardship Relief Act of 2015, which provided physicians with a hardship exemption to Stage 2 meaningful use regulations
Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Track ICD 10 implementation
Support HR 4848 The Healthy Inpatient Procedures Act
Support HR 3014: Medical Controlled Substances Transportation Act of 2015: This bill amends the Controlled Substances Act to allow a physician to transport controlled substances to another practice setting or disaster area if the physician is registered to dispense, or conduct research with, controlled substances listed on schedules II, III, IV, or V, and the physician enters into a specific agreement with the Drug Enforcement Administration (DEA).
Repeal the Independent Payment Advisory Board (IPAB);
Track Implementation of the Affordable Care Act;
Support S. 2822 and HR 5001, The Flexibility in Electronic Health Record Reporting Act;
Support HR 2513, The Promoting Access, Competition and Equity (PACE) Act;
Support HR 4848 The Healthy Inpatient Procedures Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding of the Peer Reviewed Orthopaedic Research Program
Support the 21st Century Cures Bill
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medical Liability Reform: Work to reduce the excessive burden the liability system places on the health care delivery system
Support HR 921/S. 689 - To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42016 on Feb. 22, 2017
Original Filing: 300860801.xml
Lobbying Issues
Support H.R. 105: Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the federal antitrust laws in their negotiations with health plans and health insurance carriers
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services.
Support HR 3940, Meaningful Use Hardship Relief Act of 2015, which provided physicians with a hardship exemption to Stage 2 meaningful use regulations
Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Track ICD 10 implementation
Support HR 4848 The Healthy Inpatient Procedures Act
Support HR 3014: Medical Controlled Substances Transportation Act of 2015: This bill amends the Controlled Substances Act to allow a physician to transport controlled substances to another practice setting or disaster area if the physician is registered to dispense, or conduct research with, controlled substances listed on schedules II, III, IV, or V, and the physician enters into a specific agreement with the Drug Enforcement Administration (DEA).
Repeal the Independent Payment Advisory Board (IPAB);
Track Implementation of the Affordable Care Act;
Support S. 2822 and HR 5001, The Flexibility in Electronic Health Record Reporting Act;
Support HR 2513, The Promoting Access, Competition and Equity (PACE) Act;
Support HR 4848 The Healthy Inpatient Procedures Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding of the Peer Reviewed Orthopaedic Research Program
Support the 21st Century Cures Bill
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medical Liability Reform: Work to reduce the excessive burden the liability system places on the health care delivery system
Support HR 921/S. 689 - To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2017.
Original Filing: 300853200.xml
Lobbying Issues
Support H.R. 105: Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the federal antitrust laws in their negotiations with health plans and health insurance carriers
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services.
Support HR 3940, Meaningful Use Hardship Relief Act of 2015, which provided physicians with a hardship exemption to Stage 2 meaningful use regulations
Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Track ICD 10 implementation
Support HR 4848 The Healthy Inpatient Procedures Act
Support HR 3014: Medical Controlled Substances Transportation Act of 2015: This bill amends the Controlled Substances Act to allow a physician to transport controlled substances to another practice setting or disaster area if the physician is registered to dispense, or conduct research with, controlled substances listed on schedules II, III, IV, or V, and the physician enters into a specific agreement with the Drug Enforcement Administration (DEA).
Repeal the Independent Payment Advisory Board (IPAB);
Track Implementation of the Affordable Care Act;
Support S. 2822 and HR 5001, The Flexibility in Electronic Health Record Reporting Act;
Support HR 2513, The Promoting Access, Competition and Equity (PACE) Act;
Support HR 4848 The Healthy Inpatient Procedures Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding of the Peer Reviewed Orthopaedic Research Program
Support the 21st Century Cures Bill
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medical Liability Reform: Work to reduce the excessive burden the liability system places on the health care delivery system
Support HR 921/S. 689 - To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 20, 2016.
Original Filing: 300836524.xml
Lobbying Issues
Support H.R. 105: Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the federal antitrust laws in their negotiations with health plans and health insurance carriers
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services.
Support HR 3940, Meaningful Use Hardship Relief Act of 2015, which provided physicians with a hardship exemption to Stage 2 meaningful use regulations
Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Track ICD 10 implementation
Track implementation of MACRA (Medicare Access and CHIP Reauthorization Act)
Support HR 3014: Medical Controlled Substances Transportation Act of 2015: This bill amends the Controlled Substances Act to allow a physician to transport controlled substances to another practice setting or disaster area if the physician is registered to dispense, or conduct research with, controlled substances listed on schedules II, III, IV, or V, and the physician enters into a specific agreement with the Drug Enforcement Administration (DEA).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding of the Peer Reviewed Orthopaedic Research Program
Support the 21st Century Cures Bill
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Repeal the Independent Payment Advisory Board (IPAB)
Track implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform: Work to reduce the excessive burden the liability system places on the health care delivery system
Support HR 921/S. 689 - To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 19, 2016.
Original Filing: 300814866.xml
Lobbying Issues
Support H.R. 105: Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the federal antitrust laws in their negotiations with health plans and health insurance carriers
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services.
Support HR 3940, Meaningful Use Hardship Relief Act of 2015, which provided physicians with a hardship exemption to Stage 2 meaningful use regulations
Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Track ICD 10 implementation
Track implementation of MACRA (Medicare Access and CHIP Reauthorization Act)
Support HR 3014: Medical Controlled Substances Transportation Act of 2015: This bill amends the Controlled Substances Act to allow a physician to transport controlled substances to another practice setting or disaster area if the physician is registered to dispense, or conduct research with, controlled substances listed on schedules II, III, IV, or V, and the physician enters into a specific agreement with the Drug Enforcement Administration (DEA).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work to enhance funding for NIH.
Support funding of the Peer Reviewed Orthopaedic Research Program
Support the 21st Century Cures Bill
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Repeal the Independent Payment Advisory Board (IPAB)
Track implementation of the Affordable Care Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform: Work to reduce the excessive burden the liability system places on the health care delivery system
Support HR 921/S. 689 - To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 20, 2016.
Original Filing: 300802375.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10; Supported HR 3940 which provided physicians with a hardship exemption to Stage 2 meaningful use regulations.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program. Support the 21st Century Cures Bill.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 921/ S.689-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42015 on Feb. 11, 2016
Original Filing: 300786417.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10; Supported HR 3940 which provided physicians with a hardship exemption to Stage 2 meaningful use regulations.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program. Support the 21st Century Cures Bill.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 921/ S.689-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2016.
Original Filing: 300783624.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10; Supported HR 3940 which provided physicians with a hardship exemption to Stage 2 meaningful use regulations.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program. Support the 21st Century Cures Bill.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 921/ S.689-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300763775.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program. Support the 21st Century Cures Bill.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 921/ S.689-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 10, 2015.
Original Filing: 300733186.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program. Support the 21st Century Cures Bill.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 921/ S.689-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q12015 on Dec. 6, 2016
Original Filing: 300842471.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 921/ S.689-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 20, 2015.
Original Filing: 300727477.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 921/ S.689-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42014 on Feb. 11, 2015
Original Filing: 300710719.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 3722 / S.2220-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300703265.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 3722 / S.2220-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300683274.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 3722 / S.2220-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 21, 2014.
Original Filing: 300666010.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 3722 / S.2220-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 22, 2014.
Original Filing: 300649524.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 3722 / S.2220-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2013
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 24, 2014.
Original Filing: 300628978.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Affordable Care Act (ACA);
Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medical Liability Reform;
Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
H.R. 3722-To provide protection for certain sports medicine professionals who provide medical services in a secondary state
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2013
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q32013 on Dec. 6, 2016
Original Filing: 300842477.xml
Lobbying Issues
Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care
professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
MMM Issues:
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA): Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research Program. To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2013
In Q3, AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS had in-house lobbyists. The report was filed on Nov. 12, 2013.
Original Filing: 300609636.xml
Lobbying Issues
Quality Health Care Coalition Act: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Affordable Care Act (ACA): Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medical Liability Reform: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Work with NIAMS Coalition to enhance funding for NIH. Peer Reviewed Orthopaedic Research Program.
To provide protection for certain sports medicine professionals who provide medical services in a secondary state.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2013
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 23, 2014.
Original Filing: 300689944.xml
Lobbying Issues
Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
MMM Issues:
Sustainable Growth Rate (SGR) issue; In-Office Ancillary Services: Protect Stark law exception to allow timely access to quality medical services; Ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Improve the quality of musculoskeletal care; Quality measurement; ICD-10
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA): Provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Repeal Independent Payment Advisory Board (IPAB).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medical Liability Reform: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Food & Drug: To provide for reasonable limits for conflict for interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.
Medical Device Safety: To amend the FDA Act with respect to liability under State and Local requirements respecting devices. Food & Drug Administration Globalization: to provide for the safety of medical devise manufactures in foreign countries. Pathways for Biosimilars: Provide a pathway for FDA approval of complex biological products for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2013
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q22013 on June 5, 2013
Original Filing: 300568067.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on May 6, 2013.
Original Filing: 300566681.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 30, 2013.
Original Filing: 300544479.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Dec. 21, 2012.
Original Filing: 300524776.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q22012 on July 16, 2012
Original Filing: 300485264.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q12012 on April 19, 2012
Original Filing: 300467241.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42011 on Feb. 2, 2012
Original Filing: 300455052.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q32011 on Feb. 26, 2014
Original Filing: 300630820.xml
Lobbying Issues
H.R. 1493- Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals form the Federal antitrust laws in their negotiations with health plans and health insurance issuers
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1021/S.1548- Access to Americas Orthopedic Service Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal disease, conditions, and injuries, to conduct a longitudinal study on aging, and for other purposes
H.R. 3693- Ensuring the Future Physician Workforce Act of 2009
H.R. 4851-Continuing Extension Act 2010
H.J. RES 45- Increasing the statutory limit on the public debt
H.R. 3962- Affordable Health Care for American Act
H.R. 3961-Medicare Physician Payment Reform Act of 2009
H.R. 4985- Medicare Decisions Accountability Act of 2010
H.R. 4872- Health Care and Education Reconciliation Act of 2010
H.R. 3590- Patient Protection and Affordable Care Act
H.R. 3200-Americas Affordable Health Choices Act of 2009: provide affordable, quality health care for all American and reduce the growth in health care spending, and for other purposes.
H.R. 1678- Mitigation the Impact of Uncompensated Service and Time Act of 2009: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency medical Treatment and labor Act.
H.R. 3856- Bone Health Promotion and Research Act of 2009: Amends the Public Health Service Act to : (1) authorize the Secretary of Health and Human Services (HHS) to develop and implant a National Bone Health Program for the control, Prevention, and surveillance of osteoporosis and related bone diseases and to coordinate and carry out nation education and outreach activities in support of such program: (2) authorize the Secretary to award grants to state and Indian tribes for comprehensive osteoporosis and related bone disease control and prevention programs: and (3) award grants or enter into cooperative agreement for the collection, analysis, and reporting of data on osteoporosis and related bone diseases, including ontogenesis imperfect and Pagets disease of the bone.
Surgical Workforce Shortage
Truth and Transparency
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and healthy Babies Access to Care Act: enact a stacked Cap on all liability payments awarded to medical liability suits against ob. /gynecologists.
45-Medical Care Access protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1346/S.540 Medical Device Safety Act of 2009: to amend the Federal Food Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices
H.R. 3590-Partient Protection and Affordable Care Act
H.R. 2400-Strategies to Address Antimicrobial Resistance Act
H.R. 2813- National Knee and Hip Replacement Registry Act of 2009
H.R> 1549/S.619-Presevation of Antibiotics for Medical Treatment Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Appropriations
H.R. 3326/S.9975 Department of Defense Apporpriations Act, 2010
Supplemental Department of Defense Apporpriations Act, 2011
Department of Defense Apporpriations Act, 2011 Labor/HHS Educations Appropriations Act, 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1829/S.950- Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.
H.R. 3693- Ensuring the Future Physician Workforce Act of 2009
H.R. 4851-Continuing Extension Act 2010H.J. RES 45- Increasing the statutory limit on the public debt
H.R. 3962- Affordable Health Care for American Act
H.R. 3962-The Presevation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3961-Medicare Physician Payment Reform Act of 2009
H.R. 4985- Medicare Decisions Accountability Act of 2010
H.R. 4872- Health Care and Education Reconciliation Act of 2010
H.R. 3590-Partient Protection and Affordable Care Act
H.R. 1031-Health Information Technology Promotion Act of 2009
H.R. 1911- American Recovery & Reinvestment Act (ARRA)
Health Information Technology Meaningful Use
StarkII- Physician Ban on Self-referral and Other Fraud & Abuse: ensure the Stark laws do not prevent timely access to quality medical services.
Surgical Workforce Shortage
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2011
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 17, 2011.
Original Filing: 300415543.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a longitudinal study on aging, and for other purposesH.R. 3693 - Ensuring the Future Physician Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010
H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 3856 - Bone Health Promotion and Research Act of 2009: Amends the Public Health Service Act to: (1) authoirize the Secretary of Health and Human Services (HHS) to develop and implement a National Bone Health Program for the control, preention, and surveillance of osteoposoris and related bone diseases and to coordinate and carry out national education and outreach activities in support of such program; (2) authorize the Secretary to award grants to states and Indian tribes for comprehensive osteoporosis and related bone disease control and prevention programs; and (3) award grants or enter into cooperative agreements for the collection, analysis, and reporting of data on osteopososis and related bone diseases, including osteogenesis imperfecta and Paget's disease of the bone.
Surgical Workforce Shortage
Truth and Transparency
.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynecologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices. H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 2400 - Strategies to Address Antimicrobial Resisance Act
H.R. 2813 - National Knee and Hip Replacement Registry Act of 2009
H.R. 1549/S.619 - Preservation of Antibiotics for Medical Treatment Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Appropriations
H.R. 3326/S.9975 - Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Supplemental Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Department of Defense Appropriations Act, 2011H.R. _____/S.______ - Labor/HHS/Education Appropriations Act, 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.
H.R. 3693 - Ensuring the Future Physican Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3962 - The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 1031 - Health Information Technology Promotion Act of 2009
H.R. 1911 - American Recovery & Reinvestment Act (ARRA)
Health Information Technology Meaningful Use
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Surgical Workforce Shortage
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 18, 2011.
Original Filing: 300392470.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a longitudinal study on aging, and for other purposesH.R. 3693 - Ensuring the Future Physician Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010
H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 3856 - Bone Health Promotion and Research Act of 2009: Amends the Public Health Service Act to: (1) authoirize the Secretary of Health and Human Services (HHS) to develop and implement a National Bone Health Program for the control, preention, and surveillance of osteoposoris and related bone diseases and to coordinate and carry out national education and outreach activities in support of such program; (2) authorize the Secretary to award grants to states and Indian tribes for comprehensive osteoporosis and related bone disease control and prevention programs; and (3) award grants or enter into cooperative agreements for the collection, analysis, and reporting of data on osteopososis and related bone diseases, including osteogenesis imperfecta and Paget's disease of the bone.
Surgical Workforce Shortage
Truth and Transparency
.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynecologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices. H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 2400 - Strategies to Address Antimicrobial Resisance Act
H.R. 2813 - National Knee and Hip Replacement Registry Act of 2009
H.R. 1549/S.619 - Preservation of Antibiotics for Medical Treatment Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Appropriations
H.R. 3326/S.9975 - Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Supplemental Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Department of Defense Appropriations Act, 2011H.R. _____/S.______ - Labor/HHS/Education Appropriations Act, 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.
H.R. 3693 - Ensuring the Future Physican Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3962 - The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 1031 - Health Information Technology Promotion Act of 2009
H.R. 1911 - American Recovery & Reinvestment Act (ARRA)
Health Information Technology Meaningful Use
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Surgical Workforce Shortage
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on May 13, 2011.
Original Filing: 300383789.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a longitudinal study on aging, and for other purposesH.R. 3693 - Ensuring the Future Physician Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010
H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 3856 - Bone Health Promotion and Research Act of 2009: Amends the Public Health Service Act to: (1) authoirize the Secretary of Health and Human Services (HHS) to develop and implement a National Bone Health Program for the control, preention, and surveillance of osteoposoris and related bone diseases and to coordinate and carry out national education and outreach activities in support of such program; (2) authorize the Secretary to award grants to states and Indian tribes for comprehensive osteoporosis and related bone disease control and prevention programs; and (3) award grants or enter into cooperative agreements for the collection, analysis, and reporting of data on osteopososis and related bone diseases, including osteogenesis imperfecta and Paget's disease of the bone.
Surgical Workforce Shortage
Truth and Transparency
.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynecologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices. H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 2400 - Strategies to Address Antimicrobial Resisance Act
H.R. 2813 - National Knee and Hip Replacement Registry Act of 2009
H.R. 1549/S.619 - Preservation of Antibiotics for Medical Treatment Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Appropriations
H.R. 3326/S.9975 - Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Supplemental Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Department of Defense Appropriations Act, 2011H.R. _____/S.______ - Labor/HHS/Education Appropriations Act, 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.
H.R. 3693 - Ensuring the Future Physican Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3962 - The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 1031 - Health Information Technology Promotion Act of 2009
H.R. 1911 - American Recovery & Reinvestment Act (ARRA)
Health Information Technology Meaningful Use
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Surgical Workforce Shortage
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42010 on May 17, 2011
Original Filing: 300384061.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42010 on Feb. 11, 2011
Original Filing: 300357847.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.Ensure investments in health to produce interoperable and compatible systems/programs.
Funding to help award recipients defray the cost of data collection requirements.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.Mitigating the Impact of Uncompensated Service and Time: Amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Access to America's Orthopedic Services Act: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Enact a "stacked cap" on all liability payments awarded to medical liability suits against OB/Gynecologists.
Medical Care Access: Improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Initiatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug: To provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.Medical Device Safety: To amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
Food and Drug Administration Globalization: To provide for the safety of medical devices manufactured in foreign countries.
Pathway for Biosimilars: Provide a pathway for the FDA approval of complex biological products from a reference product.
Promote Innovation and Access to Life-Saving Federal Medical Programs: Establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 27, 2010.
Original Filing: 300330957.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a longitudinal study on aging, and for other purposesH.R. 3693 - Ensuring the Future Physician Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010
H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 3856 - Bone Health Promotion and Research Act of 2009: Amends the Public Health Service Act to: (1) authoirize the Secretary of Health and Human Services (HHS) to develop and implement a National Bone Health Program for the control, preention, and surveillance of osteoposoris and related bone diseases and to coordinate and carry out national education and outreach activities in support of such program; (2) authorize the Secretary to award grants to states and Indian tribes for comprehensive osteoporosis and related bone disease control and prevention programs; and (3) award grants or enter into cooperative agreements for the collection, analysis, and reporting of data on osteopososis and related bone diseases, including osteogenesis imperfecta and Paget's disease of the bone.
Surgical Workforce Shortage
Truth and Transparency
.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynecologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices. H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 2400 - Strategies to Address Antimicrobial Resisance Act
H.R. 2813 - National Knee and Hip Replacement Registry Act of 2009
H.R. 1549/S.619 - Preservation of Antibiotics for Medical Treatment Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Appropriations
H.R. 3326/S.9975 - Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Supplemental Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Department of Defense Appropriations Act, 2011H.R. _____/S.______ - Labor/HHS/Education Appropriations Act, 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.
H.R. 3693 - Ensuring the Future Physican Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3962 - The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 1031 - Health Information Technology Promotion Act of 2009
H.R. 1911 - American Recovery & Reinvestment Act (ARRA)
Health Information Technology Meaningful Use
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Surgical Workforce Shortage
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300299163.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a longitudinal study on aging, and for other purposesH.R. 3693 - Ensuring the Future Physician Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010
H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 3856 - Bone Health Promotion and Research Act of 2009: Amends the Public Health Service Act to: (1) authoirize the Secretary of Health and Human Services (HHS) to develop and implement a National Bone Health Program for the control, preention, and surveillance of osteoposoris and related bone diseases and to coordinate and carry out national education and outreach activities in support of such program; (2) authorize the Secretary to award grants to states and Indian tribes for comprehensive osteoporosis and related bone disease control and prevention programs; and (3) award grants or enter into cooperative agreements for the collection, analysis, and reporting of data on osteopososis and related bone diseases, including osteogenesis imperfecta and Paget's disease of the bone.
Surgical Workforce Shortage
Truth and Transparency
.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynecologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices. H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 2400 - Strategies to Address Antimicrobial Resisance Act
H.R. 2813 - National Knee and Hip Replacement Registry Act of 2009
H.R. 1549/S.619 - Preservation of Antibiotics for Medical Treatment Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trauma Appropriations
H.R. 3326/S.9975 - Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Supplemental Department of Defense Appropriations Act, 2010
H.R. _____/S.______ - Department of Defense Appropriations Act, 2011H.R. _____/S.______ - Labor/HHS/Education Appropriations Act, 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.
H.R. 3693 - Ensuring the Future Physican Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3962 - The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 1031 - Health Information Technology Promotion Act of 2009
H.R. 1911 - American Recovery & Reinvestment Act (ARRA)
Health Information Technology Meaningful Use
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Surgical Workforce Shortage
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300271634.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposesH.R. 3693 - Ensuring the Future Physician Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010
H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
Surgical Workforce Shortage
Truth and Transparency
.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices. (check on this)H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
H.R. 759 - The Food and Drug Administration Globalization Act of 2009: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 1548 - Pathway for Biosimilars Act: provides a pathway for the FDA approval of complex biological products from a reference product.
H.R. 1427/S.726 - Promoting Innovation and Access Life-Saving Medicare Act: establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.
H.R. 3693 - Ensuring the Future Physican Workforce Act of 2009
H.R. 4851 - Continuing Extension Act of 2010H.J. RES. 45 - Increasing the statutory limit on the public debt
H.R. 3962 - Affordable Health Care for America Act
H.R. 3961 - Medicare Physician Payment Reform Act of 2009
H.R. 4985 - Medicare Decisions Accountability Act of 2010
H.R. 4872 - Health Care and Education Reconciliation Act of 2010
H.R. 3590 - Patient Protection and Affordable Care Act
H.R. 1031 - Health Information Technology Promotion Act of 2009
H.R. 1911 - American Recovery & Reinvestment Act (ARRA)
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Surgical Workforce Shortage
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42009 on April 7, 2010
Original Filing: 300254862.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1031 - Health Information Technology Promotion Act of 2009: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 1911 - American Recovery & Reinvestment Act (ARRA): funding to help award recipients defray the cost of data collection re quirements initiated pursuant to such Act, and for other purposes.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
H.R. 759 - The Food and Drug Administration Globalization Act of 2009: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 1548 - Pathway for Biosimilars Act: provides a pathway for the FDA approval of complex biological products from a reference product.
H.R. 1427/S.726 - Promoting Innovation and Access Life-Saving Medicare Act: establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300240277.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1031 - Health Information Technology Promotion Act of 2009: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 1911 - American Recovery & Reinvestment Act (ARRA): funding to help award recipients defray the cost of data collection re quirements initiated pursuant to such Act, and for other purposes.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
H.R. 759 - The Food and Drug Administration Globalization Act of 2009: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 1548 - Pathway for Biosimilars Act: provides a pathway for the FDA approval of complex biological products from a reference product.
H.R. 1427/S.726 - Promoting Innovation and Access Life-Saving Medicare Act: establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 19, 2009.
Original Filing: 300211504.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1829/S.950 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1031 - Health Information Technology Promotion Act of 2009: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 1911 - American Recovery & Reinvestment Act (ARRA): funding to help award recipients defray the cost of data collection re quirements initiated pursuant to such Act, and for other purposes.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200 - America's Affordable Health Choices Act of 2009: provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009: amend the Internal Revenue code of 1986 to allow a bad debt deduction to doctors to partially offset the cost of providing uncompensated care required to be provided under amendments made by the Emergency Medical Treatment and Labor Act.
H.R. 1021/S.1548 - Access to America's Orthopedic Services Act of 2009: Musculoskeletal Disease and Condition Legislation to improve research, diagnosis, and treatment of musculoskeletal diseases, conditions, and injuries, to conduct a lingitudinal study on aging, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.45 - Medical Care Access Protection Act of 2009: improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system.
Prompt Payment Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 1346/S.540 - Medical Device Safety Act of 2009: to amend the Federal Food, Drug and Cosmetic Act with respect to liability under State and local requirements respecting devices.
H.R. 759 - The Food and Drug Administration Globalization Act of 2009: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 1548 - Pathway for Biosimilars Act: provides a pathway for the FDA approval of complex biological products from a reference product.
H.R. 1427/S.726 - Promoting Innovation and Access Life-Saving Medicare Act: establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 16, 2009.
Original Filing: 300179892.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1829 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1031 - Health Information Technology Act of 2009: ensure investments in health to produce interoperable and compatible systems/programs.
American Recovery & Reinvestment Act (ARRA)
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009
Health Americans Act
H.R. 1021 - Access to America's Orthopedic Services Act of 2009: Musculoskeleltal Disease and Condition Legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
Medical Care Access Protection Act of 2009
Prompt Paymnet Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 1356/S.540 - Medical Device Safety Act of 2009: to amend the Food, Drug and Cosmetic Act with respect to liability under state and local requirements for medical devices.
H.R. 759 - The Food and Drug Administration Globalization Act of 2009: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 1548 - Pathway for Biosimilars Act: provides a pathway for the FDA approval of complex biological products from a reference product.
H.R. 1427 - Promoting Innovation and Access Life-Saving Medicare Act: establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300165813.xml
Lobbying Issues
H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1829 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1031 - Health Information Technology Act of 2009: ensure investments in health to produce interoperable and compatible systems/programs.
American Recovery & Reinvestment Act (ARRA)
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009
Health Americans Act
H.R. 1021 - Access to America's Orthopedic Services Act of 2009: Musculoskeleltal Disease and Condition Legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
Medical Care Access Protection Act of 2009
Prompt Paymnet Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 1356/S.540 - Medical Device Safety Act of 2009: to amend the Food, Drug and Cosmetic Act with respect to liability under state and local requirements for medical devices.
H.R. 759 - The Food and Drug Administration Globalization Act of 2009: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 1548 - Pathway for Biosimilars Act: provides a pathway for the FDA approval of complex biological products from a reference product.
H.R. 1427 - Promoting Innovation and Access Life-Saving Medicare Act: establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
American Association of Orthopaedic Surgeons amended a lobbying report for in-house lobbying in Q42008 on May 17, 2011
Original Filing: 300384047.xml
Lobbying Issues
H.R. 3341 - Quality Health Care Coalition Act of 2007: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1552/S.932 - Medicare Patient Access to Physical Therapists Act of 2007: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1293/S.1338 - Access to Medicare Imaging Act of 2007: place a 2 year moratorium on payment cuts to imaging services.
H.R. 1934 - Prompt Payment Improvement Act of 2007: bring federal attention to prompt payment reform currently regulated on the state level.
H.R. 3038 - Medicare Physician Payment Reform Act of 2007: reform Medicare physician payment formula
H.R. 1408 - Health Information Technology Act of 2007: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 2749/S.1519 - Voluntary Medicare Quality Reporting Act of 2007: promote a process for quality measure development, approval and implementation. Use physician's quality assistance fund toward physician payment reform.
S.1693 - Wired for Health Care Quality Act: prevent the release of raw Medicare claims data that may be used/interpreted to reflect quality.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
H.R. 5613 - Protecting the Medicaid Safety Net Act of 2008: extend certain moratoria and impose additional moratoria on certain Medicaid regulations through April 1, 2009.
Farm Bill Conference Report/H.R. 2419: ensure that provisions to restrict physicians' abilities to responsibly invest in hospitals are not included in final bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3162 - Children's Health and Medicare Protection Act of 2007: promote a permanent solution to the flawed Medicare payment formula.
H.R. 6478 - Access to America's Orthopedic Services Act of 2008: Musculoskeleltal Disease and Condition Legislation.
H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008: SGR and physician reimbursement under Medicare
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.244 - Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.243 - Medical Care Access Protection Act of 2007
H.R. 1934 - Prompt Paymnet Improvement Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1082/H.R. 2900 - Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 2900/S.1082 - Food and Drug Amendments Act of 2007: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to provide unique identification systems for medical devices.
S.830/H.R. 1494 - Pediatric Medical Devices Safety and Improvement Act: to stimulate development of necessary medical devices for the pediatric population.
H.R. 1956/H.R. 5629/H.R. 1038/S.623 - Regulation Devices Biologics and Combination Products by the FDA: to provide a pathway for follow-on biologics that would not allow for interchangeability without express physician approval.
The Food and Drug Administration Globalization Act of 2008: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 6381 - Medical Device Safety Act of 2008: to amend the Food, Drug and Cosmetic Act with respect to liability under state and local requirements for medical devices.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Jan. 20, 2009.
Original Filing: 300128393.xml
Lobbying Issues
H.R. 3341 - Quality Health Care Coalition Act of 2007: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1552/S.932 - Medicare Patient Access to Physical Therapists Act of 2007: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1293/S.1338 - Access to Medicare Imaging Act of 2007: place a 2 year moratorium on payment cuts to imaging services.
H.R. 1934 - Prompt Payment Improvement Act of 2007: bring federal attention to prompt payment reform currently regulated on the state level.
H.R. 3038 - Medicare Physician Payment Reform Act of 2007: reform Medicare physician payment formula
H.R. 1408 - Health Information Technology Act of 2007: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 2749/S.1519 - Voluntary Medicare Quality Reporting Act of 2007: promote a process for quality measure development, approval and implementation. Use physician's quality assistance fund toward physician payment reform.
S.1693 - Wired for Health Care Quality Act: prevent the release of raw Medicare claims data that may be used/interpreted to reflect quality.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
H.R. 5613 - Protecting the Medicaid Safety Net Act of 2008: extend certain moratoria and impose additional moratoria on certain Medicaid regulations through April 1, 2009.
Farm Bill Conference Report/H.R. 2419: ensure that provisions to restrict physicians' abilities to responsibly invest in hospitals are not included in final bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3162 - Children's Health and Medicare Protection Act of 2007: promote a permanent solution to the flawed Medicare payment formula.
H.R. 6478 - Access to America's Orthopedic Services Act of 2008: Musculoskeleltal Disease and Condition Legislation.
H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008: SGR and physician reimbursement under Medicare
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.244 - Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.243 - Medical Care Access Protection Act of 2007
H.R. 1934 - Prompt Paymnet Improvement Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1082/H.R. 2900 - Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 2900/S.1082 - Food and Drug Amendments Act of 2007: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to provide unique identification systems for medical devices.
S.830/H.R. 1494 - Pediatric Medical Devices Safety and Improvement Act: to stimulate development of necessary medical devices for the pediatric population.
H.R. 1956/H.R. 5629/H.R. 1038/S.623 - Regulation Devices Biologics and Combination Products by the FDA: to provide a pathway for follow-on biologics that would not allow for interchangeability without express physician approval.
The Food and Drug Administration Globalization Act of 2008: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 6381 - Medical Device Safety Act of 2008: to amend the Food, Drug and Cosmetic Act with respect to liability under state and local requirements for medical devices.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on Oct. 16, 2008.
Original Filing: 300095519.xml
Lobbying Issues
H.R. 3341 - Quality Health Care Coalition Act of 2007: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1552/S.932 - Medicare Patient Access to Physical Therapists Act of 2007: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1293/S.1338 - Access to Medicare Imaging Act of 2007: place a 2 year moratorium on payment cuts to imaging services.
H.R. 1934 - Prompt Payment Improvement Act of 2007: bring federal attention to prompt payment reform currently regulated on the state level.
H.R. 3038 - Medicare Physician Payment Reform Act of 2007: reform Medicare physician payment formula
H.R. 1408 - Health Information Technology Act of 2007: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 2749/S.1519 - Voluntary Medicare Quality Reporting Act of 2007: promote a process for quality measure development, approval and implementation. Use physician's quality assistance fund toward physician payment reform.
S.1693 - Wired for Health Care Quality Act: prevent the release of raw Medicare claims data that may be used/interpreted to reflect quality.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
H.R. 5613 - Protecting the Medicaid Safety Net Act of 2008: extend certain moratoria and impose additional moratoria on certain Medicaid regulations through April 1, 2009.
Farm Bill Conference Report/H.R. 2419: ensure that provisions to restrict physicians' abilities to responsibly invest in hospitals are not included in final bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3162 - Children's Health and Medicare Protection Act of 2007: promote a permanent solution to the flawed Medicare payment formula.
H.R. 6478 - Access to America's Orthopedic Services Act of 2008: Musculoskeleltal Disease and Condition Legislation.
H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008: SGR and physician reimbursement under Medicare
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.244 - Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.243 - Medical Care Access Protection Act of 2007
H.R. 1934 - Prompt Paymnet Improvement Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1082/H.R. 2900 - Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 2900/S.1082 - Food and Drug Amendments Act of 2007: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to provide unique identification systems for medical devices.
S.830/H.R. 1494 - Pediatric Medical Devices Safety and Improvement Act: to stimulate development of necessary medical devices for the pediatric population.
H.R. 1956/H.R. 5629/H.R. 1038/S.623 - Regulation Devices Biologics and Combination Products by the FDA: to provide a pathway for follow-on biologics that would not allow for interchangeability without express physician approval.
The Food and Drug Administration Globalization Act of 2008: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 6381 - Medical Device Safety Act of 2008: to amend the Food, Drug and Cosmetic Act with respect to liability under state and local requirements for medical devices.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on July 17, 2008.
Original Filing: 300069917.xml
Lobbying Issues
H.R. 3341 - Quality Health Care Coalition Act of 2007: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1552/S.932 - Medicare Patient Access to Physical Therapists Act of 2007: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1293/S.1338 - Access to Medicare Imaging Act of 2007: place a 2 year moratorium on payment cuts to imaging services.
H.R. 1934 - Prompt Payment Improvement Act of 2007: bring federal attention to prompt payment reform currently regulated on the state level.
H.R. 3038 - Medicare Physician Payment Reform Act of 2007: reform Medicare physician payment formula
H.R. 1408 - Health Information Technology Act of 2007: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 2749/S.1519 - Voluntary Medicare Quality Reporting Act of 2007: promote a process for quality measure development, approval and implementation. Use physician's quality assistance fund toward physician payment reform.
S.1693 - Wired for Health Care Quality Act: prevent the release of raw Medicare claims data that may be used/interpreted to reflect quality.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
H.R. 5613 - Protecting the Medicaid Safety Net Act of 2008: extend certain moratoria and impose additional moratoria on certain Medicaid regulations through April 1, 2009.
Farm Bill Conference Report/H.R. 2419: ensure that provisions to restrict physicians' abilities to responsibly invest in hospitals are not included in final bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3162 - Children's Health and Medicare Protection Act of 2007: promote a permanent solution to the flawed Medicare payment formula.
H.R. 6478 - Access to America's Orthopedic Services Act of 2008: Musculoskeleltal Disease and Condition Legislation.
H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008: SGR and physician reimbursement under Medicare
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.244 - Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.243 - Medical Care Access Protection Act of 2007
H.R. 1934 - Prompt Paymnet Improvement Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1082/H.R. 2900 - Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 2900/S.1082 - Food and Drug Amendments Act of 2007: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to provide unique identification systems for medical devices.
S.830/H.R. 1494 - Pediatric Medical Devices Safety and Improvement Act: to stimulate development of necessary medical devices for the pediatric population.
H.R. 1956/H.R. 5629/H.R. 1038/S.623 - Regulation Devices Biologics and Combination Products by the FDA: to provide a pathway for follow-on biologics that would not allow for interchangeability without express physician approval.
The Food and Drug Administration Globalization Act of 2008: to provide for the safety of medical devices manufactured in foreign countries.
H.R. 6381 - Medical Device Safety Act of 2008: to amend the Food, Drug and Cosmetic Act with respect to liability under state and local requirements for medical devices.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, American Association of Orthopaedic Surgeons had in-house lobbyists. The report was filed on April 18, 2008.
Original Filing: 300044740.xml
Lobbying Issues
H.R. 3341 - Quality Health Care Coalition Act of 2007: ensure patient access to quality health care.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
H.R. 1552/S.932 - Medicare Patient Access to Physical Therapists Act of 2007: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services.H.R. 1293/S.1338 - Access to Medicare Imaging Act of 2007: place a 2 year moratorium on payment cuts to imaging services.
H.R. 1934 - Prompt Payment Improvement Act of 2007: bring federal attention to prompt payment reform currently regulated on the state level.
H.R. 3038 - Medicare Physician Payment Reform Act of 2007: reform Medicare physician payment formula
H.R. 1408 - Health Information Technology Act of 2007: ensure investments in health to produce interoperable and compatible systems/programs.
H.R. 2749/S.1519 - Voluntary Medicare Quality Reporting Act of 2007: promote a process for quality measure development, approval and implementation. Use physician's quality assistance fund toward physician payment reform.
S.1693 - Wired for Health Care Quality Act: prevent the release of raw Medicare claims data that may be used/interpreted to reflect quality.
Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare.
Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed.
Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost.
Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.
H.R. 5613 - Protecting the Medicaid Safety Net Act of 2008: extend certain moratoria and impose additional moratoria on certain Medicaid regulations through April 1, 2009.
Farm Bill Conference Report/H.R. 2419: ensure that provisions to restrict physicians' abilities to responsibly invest in hospitals are not included in final bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3162 - Children's Health and Medicare Protection act of 2007: promote a permanent solution to the flawed Medicare payment formula.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.244 - Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists.
S.243 - Medical Care Access Protection Act of 2007
H.R. 1934 - Prompt Paymnet Improvement Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1082 - Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices.H.R. 2900 - Food and Drug amendments Act of 2007: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to provide unique identification systems for medical devices.
S.830 - Pediatric Medical Devices Safety and Improvement Act: to stimulate development of necessary medical devices for the pediatric population.
Regulation Devices Biologics and Combination Products by the FDA: to provide a pathway for follow-on biologics that would not allow for interchangeability without express physician approval.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS filed a lobbying registration on Feb. 13, 2008 for in-house lobbying efforts, effective Feb. 14, 2008.
Original Filing: 300025336.xml
Issue(s) they said they’d lobby about: Patient access to quality health care; FDA issues; Medicare; Medicaid; medical devices; device biologics; tort reform .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...